Report for Camanni F

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa - Fassino_2003_J.Endocrinol.Invest_26_503
Author(s) : Fassino S , Lanfranco F , Abbate Daga G , Mondelli V , Destefanis S , Rovera GG , Camanni F , Ghigo E , Arvat E , Gianotti L
Ref : J Endocrinol Invest , 26 :503 , 2003
Abstract : Fassino_2003_J.Endocrinol.Invest_26_503
ESTHER : Fassino_2003_J.Endocrinol.Invest_26_503
PubMedSearch : Fassino_2003_J.Endocrinol.Invest_26_503
PubMedID: 12952362

Title : GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism - Procopio_1999_Minerva.Endocrinol_24_107
Author(s) : Procopio M , Maccario M , Savio P , Valetto MR , Aimaretti G , Grottoli S , Oleandri SE , Baffoni C , Tassone F , Arvat E , Camanni F , Ghigo E
Ref : Minerva Endocrinol , 24 :107 , 1999
Abstract : Procopio_1999_Minerva.Endocrinol_24_107
ESTHER : Procopio_1999_Minerva.Endocrinol_24_107
PubMedSearch : Procopio_1999_Minerva.Endocrinol_24_107
PubMedID: 10953725

Title : GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism - Procopio_1998_Panminerva.Med_40_13
Author(s) : Procopio M , Maccario M , Savio P , Valetto MR , Aimaretti G , Grottoli S , Oleandri SE , Baffoni C , Tassone F , Arvat E , Camanni F , Ghigo E
Ref : Panminerva Med , 40 :13 , 1998
Abstract : Procopio_1998_Panminerva.Med_40_13
ESTHER : Procopio_1998_Panminerva.Med_40_13
PubMedSearch : Procopio_1998_Panminerva.Med_40_13
PubMedID: 9573747

Title : Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus - Martina_1997_Horm.Metab.Res_29_180
Author(s) : Martina V , Bruno G , Tagliabue M , Maccario M , Bertaina S , Zumpano E , Arvat E , Ghigo E , Camanni F
Ref : Hormone & Metabolic Research , 29 :180 , 1997
Abstract : Martina_1997_Horm.Metab.Res_29_180
ESTHER : Martina_1997_Horm.Metab.Res_29_180
PubMedSearch : Martina_1997_Horm.Metab.Res_29_180
PubMedID: 9178028

Title : Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man - Arvat_1997_Clin.Endocrinol.(Oxf)_47_495
Author(s) : Arvat E , Di Vito L , Ramunni J , Gianotti L , Giordano R , Deghenghi R , Camanni F , Ghigo E
Ref : Clinical Endocrinology (Oxf) , 47 :495 , 1997
Abstract : Arvat_1997_Clin.Endocrinol.(Oxf)_47_495
ESTHER : Arvat_1997_Clin.Endocrinol.(Oxf)_47_495
PubMedSearch : Arvat_1997_Clin.Endocrinol.(Oxf)_47_495
PubMedID: 9404449